A detailed history of Parallax Volatility Advisers, L.P. transactions in Novartis Ag stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 9,700 shares of NVS stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,700
Previous 700 1285.71%
Holding current value
$1.01 Million
Previous $74,000 1406.76%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$79.7 - $88.13 $10.8 Million - $11.9 Million
135,356 Added 3717.55%
138,997 $12.2 Million
Q3 2021

Nov 15, 2021

BUY
$81.78 - $95.14 $293,099 - $340,981
3,584 Added 6287.72%
3,641 $298,000
Q4 2020

Feb 16, 2021

BUY
$78.07 - $94.43 $4,449 - $5,382
57 New
57 $5,000
Q4 2020

Feb 16, 2021

SELL
$78.07 - $94.43 $64,251 - $77,715
-823 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$82.14 - $91.0 $66,286 - $73,437
807 Added 5043.75%
823 $72,000
Q2 2020

Aug 14, 2020

SELL
$80.93 - $91.1 $196,012 - $220,644
-2,422 Reduced 99.34%
16 $1,000
Q4 2019

Feb 14, 2020

SELL
$84.35 - $95.37 $468,479 - $529,684
-5,554 Reduced 69.49%
2,438 $231,000
Q3 2019

Nov 14, 2019

SELL
$85.54 - $94.26 $14.4 Million - $15.8 Million
-167,931 Reduced 95.46%
7,992 $694,000
Q2 2019

Aug 14, 2019

SELL
$75.4 - $92.8 $889,116 - $1.09 Million
-11,792 Reduced 6.28%
175,923 $16.1 Million
Q1 2019

May 15, 2019

BUY
$75.32 - $86.15 $14.1 Million - $16.1 Million
187,145 Added 32832.46%
187,715 $18 Million
Q4 2018

Feb 14, 2019

SELL
$73.66 - $82.02 $5.63 Million - $6.26 Million
-76,383 Reduced 99.26%
570 $49,000
Q3 2018

Nov 14, 2018

BUY
$66.94 - $77.43 $5.15 Million - $5.96 Million
76,953 New
76,953 $6.63 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.